These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11235190)

  • 1. [Weekly low dose CPT-11 for multiple lung metastases of colon cancer on an out-patient treatment: a case report].
    Sasaki K; Takasaka H; Kawasaki H; Oono K; Nakayama I; Matsunaga T; Takaoka A; Aoki S; Hamamatsu C; Hirayama T; Nakagawa N; Shibata K; Yabana T; Yamamoto Y; Hirata K
    Nihon Shokakibyo Gakkai Zasshi; 2001 Feb; 98(2):157-61. PubMed ID: 11235190
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer].
    Nishimura G; Satou T; Yoshimitsu Y; Kurosaka Y; Fujimura T; Sugiyama K; Kanno M; Yonemura Y; Miwa K; Miyazaki I
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):93-7. PubMed ID: 7826085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of lung metastasis from colon cancer treated successfully with combined chemotherapy of CPT-11 and 5'-DFUR].
    Ogata Y; Sasatomi T; Araki Y; Ishibashi N; Nozoe Y; Miyagi Y; Nakagawa M; Matono K; Kishimoto Y; Hayashi A; Mituoka M; Konishi J; Shirouzu K
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1917-21. PubMed ID: 11729488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimal dosing schedule in combination therapy with irinotecan and doxifluridine in a human colorectal cancer xenograft model].
    Yanagisawa M; Ishikawa T; Ouchi KF; Tanaka Y
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):223-30. PubMed ID: 12610870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of low-dose irinotecan for multiple lung metastases of cholangiocellular carcinoma after operation--a case report].
    Kutomi G; Katsuramaki T; Mukaiya M; Hirata K; Shimodan M; Adachi H
    Gan To Kagaku Ryoho; 2002 May; 29(5):781-4. PubMed ID: 12040685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of metastatic colon cancer treated with oxaliplatin combination chemotherapy].
    Tsujie M; Fujiwara S; Kida H; Hayashi N; Fukuchi S; Yoshida T; Ebisui C; Sakita I; Hasuike Y; Fujimoto T
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1774-5. PubMed ID: 16315937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low-dose CPT-11 against a recurrent rectal cancer--a case report].
    Takahashi Y; Omote K; Kitagata S; Mai M
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1193-6. PubMed ID: 10431589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
    Shinohara H; Killion JJ; Kuniyasu H; Kumar R; Fidler IJ
    Clin Cancer Res; 1998 Sep; 4(9):2053-63. PubMed ID: 9748119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of colon metastasis to the lung treated successfully with combined chemotherapy of CPT-11 and 5'-DFUR].
    Ojima E; Miki C; Hatada T; Inoue Y; Mohri T; Azuma T; Kusunoki M
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1845-8. PubMed ID: 12402441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of liver metastasis and extrahepatic metastasis with hepatic arterial infusion of CDDP, CPT-11, and 5-FU].
    Doi K; Ohchi T; Ogata K; Kikuchi N; Ishimoto T; Hashimoto D; Ochiai T; Muranaka T; Ogawa M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1668-70. PubMed ID: 15553678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study and pharmacokinetics of CPT-11 with 5-day continuous infusion.
    Ohe Y; Sasaki Y; Shinkai T; Eguchi K; Tamura T; Kojima A; Kunikane H; Okamoto H; Karato A; Ohmatsu H
    J Natl Cancer Inst; 1992 Jun; 84(12):972-4. PubMed ID: 1321253
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408.
    Fujishiro M; Shinkai T; Fukuda M; Tamura T; Ohe Y; Kunitoh H; Nishiwaki Y; Sekine I; Fukuda H; Saijo N
    Jpn J Clin Oncol; 2000 Nov; 30(11):487-93. PubMed ID: 11155918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of hepatic metastasis from rectal carcinoma successfully treated with pharmacokinetic modulating chemotherapy (PMC)-CPT-11 therapy].
    Matsusaka S; Oriyama T; Okada T; Chang W; Maeda S; Kondo Y; Kosaka H
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):461-4. PubMed ID: 11915740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line.
    Inoue Y; Miki C; Watanabe H; Hiro J; Toiyama Y; Ojima E; Yanagi H; Kusunoki M
    J Gastroenterol; 2006 Dec; 41(12):1149-57. PubMed ID: 17287894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly hepatic arterial infusion of 5-fluorouracil and subsequent systemic chemotherapy for liver metastases from colorectal cancer.
    Hosokawa A; Yamada Y; Shimada Y; Muro K; Matsumura Y; Fujita S; Akasu T; Moriya Y; Shirao K
    Jpn J Clin Oncol; 2003 Mar; 33(3):132-5. PubMed ID: 12672790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies of irinotecan alone and in combination with cisplatin.
    Fukuoka M; Masuda N
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S105-11. PubMed ID: 8070018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: role of drug sequence and dose.
    Cao S; Rustum YM
    Cancer Res; 2000 Jul; 60(14):3717-21. PubMed ID: 10919639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11).
    Palmer RD; Williams DM
    Med Pediatr Oncol; 2003 Jul; 41(1):78-80. PubMed ID: 12764754
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
    Cerea G; Vaghi M; Ardizzoia A; Villa S; Bucovec R; Mengo S; Gardani G; Tancini G; Lissoni P
    Anticancer Res; 2003; 23(2C):1951-4. PubMed ID: 12820485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intergroup trial fails to demonstrate a benefit with the addition of irinotecan to bolus 5-fluorouracil/leucovorin in stage III colon cancer.
    Reddy GK
    Clin Colorectal Cancer; 2004 Nov; 4(4):230-2. PubMed ID: 15555203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.